Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus.

Saved in:
Bibliographic Details
Title: Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus.
Authors: Castagna, Antonella1,2 castagna.antonella1@hsr.it, Ferrara, Micol3, Galli, Laura4, Comi, Laura5, Sterrantino, Gaetana6, Cenderello, Giovanni7, Zaccarelli, Mauro8, Focá, Emanuele9, Roncadori, Andrea10, Lazzarin, Adriano4, Focà, Emanuele11 (AUTHOR), PRESTIGIO Study Group (CORPORATE AUTHOR)
Source: Journal of Antimicrobial Chemotherapy (JAC). Jan2018, Vol. 73 Issue 1, p177-182. 6p. 2 Charts, 2 Graphs.
Database: Environment Complete
Description
ISSN:03057453
DOI:10.1093/jac/dkx371